Hospital
Minimally Invasive Surgery Hospital
Minimally Invasive Surgery Hospital was paid $1.06M by Medicaid between Jan 2018 and Jun 2024, across 20 billing codes. Its largest line is Y7506, — 50% of everything it billed.
33Billing provider infoMINIMALLY INVASIVE SURGERY HOSPITAL
LENEXA, KS 66219
LENEXA, KS 66219
33aNPI1619069275assigned 09/29/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$1.06M
24GClaims3,969
24DCodes billed20
24AFirst – last monthJan 2018 – Jun 2024
Compared with peers
Next to other General Acute Care Hospital providers in Kansas
Rank by total paid#19 of 48
Median peer was paid$461K
This provider vs. median2.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,192 | $757K | |
| 2019 | 1,038 | $221K | |
| 2020 | 695 | $32K | |
| 2021 | 391 | $14K | |
| 2022 | 116 | $2K | |
| 2023 | 368 | $25K | |
| 2024incomplete | 169 | $9K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| Y7506 | 50% | 216 | 197 | $526K | |
| X4006 | 18% | 51 | 43 | $187K | |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 12% | 760 | 727 | $127K |
| G0378 | Hospital observation service, per hour | 5.3% | 45 | 40 | $56K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 4.3% | 782 | 747 | $45K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 3.5% | 75 | 74 | $38K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 3.4% | 66 | 64 | $36K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.8% | 1,546 | 1,473 | $19K |
| 88342 | 1.4% | 45 | 45 | $15K | |
| 80053 | Comprehensive metabolic panel | <1% | 68 | 67 | $3K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 66 | 66 | $3K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 14 | 12 | $2K |
8 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBRAUN, CHRISTINA (BILLING COORDINATOR)